OXBRYTA: payments to doctors
Payments that named OXBRYTA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $7M
- Providers
- 5,768
- Transactions
- 15,769
- Average per transaction
- $443
The per-transaction average — $443 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,768 providers the average total is $1,210, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Global Blood Therapeutics, Inc. | $5,495,686 | 78.7% |
| Pfizer | $1,480,298 | 21.2% |
| PBG Puerto RICO LLC | $3,231 | 0.0% |